“…Today, mistletoe extract [V. album extract (VAE)] therapy is among the most commonly used and thoroughly studied complementary treatments in Europe (Beuth and Schierholz, 2007;Fasching et al, 2007;Molassiotis et al, 2005Molassiotis et al, , 2006aMolassiotis et al, , 2006b. Many kinds of metabolites have been isolated from the European mistletoe, and some are synthesized by the host and incorporated into V. album (Cordero et al, 1993;Giudici et al, 2004). Viscotoxins and amphipathic and basic polypeptides (Schaller et al, 1998); tyramine, phenylethylamine, choline, and acetylcholine (Hegnauer, 1966); aminoalkaloids (Amer et al, 2012); phenolic acids and flavonoids (Deliorman et al, 2002;Fukunaga et al, 1987;Luczkiewicz et al, 2001;Vicas et al, 2011); phenylpropanoids (Panossian et al, 1998;Wagner et al, 1986); terpenoids (Fukunaga et al, 1987); long-chain fatty acids and hydrocarbons as well as trace amounts of volatile components including trans-abergamotene, trans-b-farnesene, loliolide, and vomifoliol (Cebović et al, 2008); and oligosaccharides and polysaccharides (Arda et al, 2003;Jordan and Wagner, 1986) belong to active metabolites isolated from the mistletoe.…”